Effect of vitamin B12 status on selenium methylation and toxicity in rats: in vivo and in vitro studies

Toxicol Appl Pharmacol. 1993 Jan;118(1):65-72. doi: 10.1006/taap.1993.1010.

Abstract

Animals are known to convert inorganic selenium to less toxic methylated compounds such as dimethylselenide (DMSe) and trimethylselenonium (TMSe). This study investigated the role of vitamin B12, a cofactor of methionine synthetase, in selenium methylation in the rat. Vitamin B12-depleted rats expired 16% of dosed 75Se-selenite as DMSe compared to 45% for control rats and excreted less TMSe in the urine (6.1% of dose) than control (9% of dose) rats. At the same time, higher (p < 0.05) tissue (liver, kidney, muscle) selenium levels and lower (p < 0.05) blood selenium levels were found in vitamin B12-deficient rats. Primary hepatocytes from vitamin B12-deficient rats volatilized 15% of selenite in incubation medium in 5 hr as compared to 49% in hepatocytes from control rats. Hepatocytes from vitamin B12-deficient rats were less resistant to selenite toxicity. In vitro methylation of selenium with liver extract from vitamin B12-deficient rats showed one-third to one-half the rate of volatilization of selenium as compared to control rats. S-adenosylmethionine was required for this reaction. These results show that vitamin B12 deficiency significantly decreases the ability of rats to methylate selenium.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • In Vitro Techniques
  • Liver / metabolism
  • Male
  • Methylation
  • Methylmalonic Acid / urine
  • Rats
  • Rats, Sprague-Dawley
  • Selenium / metabolism*
  • Selenium / toxicity*
  • Vitamin B 12 Deficiency / metabolism*
  • Volatilization

Substances

  • Methylmalonic Acid
  • Selenium